4.7 Review

Light stimulus responsive nanomedicine in the treatment of oral squamous cell carcinoma

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 199, Issue -, Pages -

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2020.112394

Keywords

Light stimulus responsive; Oral squamous cell carcinoma; Cancer therapy; Photodynamic therapy; Photothermal therapy; Drug delivery system

Funding

  1. National Natural Science Foundation of China [81672672, 81972542]
  2. State Key Laboratory of Oral Disease Special Funded Projects

Ask authors/readers for more resources

Light stimulus responsive therapies are based on a variety of low-toxic therapeutic agents and produce anti-tumor effects only under external light stimulation, thus greatly reducing system toxicity and improving the specificity of treatment. Moreover, light stimulus responsive drug delivery system (DDS) can combine various theranostics molecules to exert synergistic therapeutic effects of various treatments, which has played an important role in cancer treatment. In this review, we introduced the light stimulus responsive cancer therapies including photodynamic therapy (PDT), photothermal therapy (PTT) and light-triggered DDS applied in the treatment of OSCC, described considerable photosensitizers (PSs) and nanomaterials used for oral cancers, which will hope to better the clinic outcome of OSCC patients. (C) 2020 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

Xin Pang, Hua-yang Fan, Ya-ling Tang, Sha-sha Wang, Ming-xin Cao, Hao-fan Wang, Lu-ling Dai, Ke Wang, Xiang-hua Yu, Jing-biao Wu, Ya-Jie Tang, Xin-hua Liang

PLOS ONE (2020)

Review Biotechnology & Applied Microbiology

CircRNAs: A New Chapter in Oral Squamous Cell Carcinoma Biology

Hua-yang Fan, Jian Jiang, Ya-jie Tang, Xin-hua Liang, Ya-ling Tang

ONCOTARGETS AND THERAPY (2020)

Article Oncology

Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma

Ke Wang, Hua-Yang Fan, Xing Pang, Mei Zhang, Xiang-Hua Yu, Jia-Shun Wu, Bing-Jun Chen, Jian Jiang, Xin-Hua Liang, Ya-Ling Tang

Summary: High expression of Dll4 is associated with invasive front of SACC, solid tumor type, high TNM grade, and high metastasis and recurrence rates. Notch1 and Dll4 are positively correlated at the invasive front, with leader cells showing high Dll4 expression and follower cells showing high Notch1 expression in a 3D culture model. Silencing Dll4 reduces migration and invasion of SACC cells, but overexpression of Notch1 can rescue these abilities. Dll4/Notch1 signaling pathway may play a role in collective invasion of SACC and could be a potential target for SACC treatment.

ONCOLOGY REPORTS (2021)

Article Oncology

Plasticity of cancer cell invasion: Patterns and mechanisms

Jia-shun Wu, Jian Jiang, Bing-jun Chen, Ke Wang, Ya-ling Tang, Xin-hua Liang

Summary: Cancer cell migration and invasion are essential components of metastatic disease, involving various mechanisms and movement strategies. During tumor progression, cancer cells exhibit distinct characteristics and reversible transitions in their motility patterns.

TRANSLATIONAL ONCOLOGY (2021)

Article Oncology

Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection

Xiao-jie Luo, Min Zheng, Ming-xin Cao, Wei-long Zhang, Mei-chang Huang, Li Dai, Ya-ling Tang, Xin-hua Liang

Summary: The study developed miRNA signatures for both HPV+ and HPV- HNSCC to predict patients' prognosis, and explored their potential biological functions. Combined results suggested that HPV+ HNSCC patients with low signature scores had better immunity and treatment sensitivity, while HPV- HNSCC patients with high scores had poor prognosis due to treatment resistance and cell metabolism dysregulation. Identified signatures for HPV+ and HPV- HNSCC are significant for patient outcomes and may serve as new biomarkers and therapeutic targets.

FRONTIERS IN ONCOLOGY (2021)

Review Oncology

Fibroblasts in cancer dormancy: foe or friend?

Li Dai, Mao Li, Wei-long Zhang, Ya-Jie Tang, Ya-ling Tang, Xin-hua Liang

Summary: This review explores the multifaceted roles of fibroblasts, including normal, senescent, cancer-associated fibroblasts (CAFs), and circulation CAFs, in tumor dormancy, relapse, metastasis, and therapy resistance, aiming to aid in the treatment of cancer metastasis.

CANCER CELL INTERNATIONAL (2021)

Article Cell Biology

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Mei Zhang, Min Zheng, Li Dai, Wei-long Zhang, Hua-yang Fan, Xiang-hua Yu, Xin Pang, Peng Liao, Bing-jun Chen, Sha-sha Wang, Ming-xin Cao, Xiang-rui Ma, Xin-hua Liang, Ya-ling Tang

Summary: The study revealed that activation of the CXCL12/CXCR4 axis in SACC may promote perineural invasion (PNI) by inducing tumor cells to differentiate towards Schwann-like cells through the Twist/S100A4 axis, accelerating cancer progression.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Review Cell Biology

Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs

Hua-yang Fan, Zhuo-li Zhu, Hong-chun Xian, Hao-fan Wang, Bing-jun Chen, Ya-Jie Tang, Ya-ling Tang, Xin-hua Liang

Summary: Podophyllotoxin (PTOX) is a biologically active compound derived from the podophyllum plant, and its derivatives, such as etoposide and teniposide, show potential for cancer treatment. Studies have revealed that PTOX derivatives exert anticancer effects by inducing cell cycle arrest and DNA/RNA breaks. Despite the development of many derivatives, research on the interactions with downstream cancer-related signaling pathways is still limited.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Correction Oncology

OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway (vol 70, pg 1015, 2021)

Xin Pang, Sha-Sha Wang, Mei Zhang, Jian Jiang, Hua-Yang Fan, Jia-Shun Wu, Hao-Fan Wang, Xin-Hua Liang, Ya-Ling Tang

CANCER IMMUNOLOGY IMMUNOTHERAPY (2022)

Correction Oncology

Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma (vol 45, pg 1011, 2021)

Ke Wang, Hua-Yang Fan, Xing Pang, Mei Zhang, Xiang-Hua Yu, Jia-Shun Wu, Bing-Jun Chen, Jian Jiang, Xin-Hua Liang, Ya-Ling Tang

ONCOLOGY REPORTS (2022)

Review Pharmacology & Pharmacy

Advances of podophyllotoxin and its derivatives: Patterns and mechanisms

Rong-jia Shi, Hua-yang Fan, Xiang-hua Yu, Ya-ling Tang, Jian Jiang, Xin-hua Liang

Summary: This review focuses on the multidirectional pharmacological properties of Podophyllotoxin (PPT) and its derivatives (PPTs), including the crosstalk with anticancer, anti-inflammatory, immunosuppression, and antiviral effects, as well as the newly uncovered mechanisms and potential of nano delivery.

BIOCHEMICAL PHARMACOLOGY (2022)

Article Dentistry, Oral Surgery & Medicine

Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor

Xiang-hua Yu, Jing-biao Wu, Hua-yang Fan, Li Dai, Hong-chun Xian, Bing-jun Chen, Peng Liao, Mei-chang Huang, Xin Pang, Mei Zhang, Xin-hua Liang, Ya-ling Tang

Summary: Artemisinin (ART) may induce vascular normalisation and inhibit tumour growth in oral squamous cell carcinoma (OSCC) through the MIF-signalling pathway.

ORAL DISEASES (2022)

Article Oncology

OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway

Xin Pang, Sha-sha Wang, Mei Zhang, Jian Jiang, Hua-yang Fan, Jia-shun Wu, Hao-fan Wang, Xin-hua Liang, Ya-ling Tang

Summary: In OSCC samples, higher expression of CMTM6 is associated with higher pathological stage, CD163+ macrophage infiltration, and PD-L1 expression. Knockdown of CMTM6 inhibits proliferative, migrative, and invasive abilities of OSCC cells, and suppresses M2 macrophage polarization in vitro by downregulating PD-L1 expression. Exosomal CMTM6 from OSCC cells promotes M2-like macrophage polarization via ERK1/2 signaling, indicating a novel crosstalk between cancer cells and immune cells in OSCC microenvironment.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)